Differences in susceptibility to inactivation of human aldehyde dehydrogenases by lipid peroxidation byproducts

Chemical Research in Toxicology

Volumn 25, Issue 3, 2012, Pages 722-729

  Yoval Sánchez, Belem ^a   Rodríguez Zavala, José S ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; ACROLEIN; ALDEHYDE DEHYDROGENASE; MALONALDEHYDE; NICOTINAMIDE ADENINE DINUCLEOTIDE;

ANIMAL CELL; ARTICLE; BINDING SITE; CATALYSIS; DETOXIFICATION; HUMAN; LIPID PEROXIDATION; MOUSE; NONHUMAN; OXIDATION;

ACROLEIN; ALDEHYDE DEHYDROGENASE; ALDEHYDES; AMINO ACID SEQUENCE; HUMANS; LIPID PEROXIDATION; MALONDIALDEHYDE; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS; SEQUENCE ALIGNMENT;

EID: 84858675338     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx2005184     Document Type: Article

References (55)

1. Leonarduzzi, G., Chiarpotto, E., Biasi, F., and Poli, G. (2005) 4-Hydroxynonenal and cholesterol oxidation products in atherosclerosis. Mol. Nutr. Food Res. 49, 1044-1049. (Pubitemid 41735564)
2. Poli, G., Sottero, B., Gargiulo, S., and Leonarduzzi, G. (2009) Cholesterol oxidation products in the vascular remodeling due to atherosclerosis. Mol. Asp. Med. 30, 180-189.
3. Srivastava, S., Sithu, S. D., Vladykovskaya, E., Haberzettl, P., Hoetker, D. J., Siddiqui, M. A., Conklin, D. J., D'Souza, S. E., and Bhatnagar, A. (2011) Oral exposure to acrolein exacerbates atherosclerosis in apoE-null mice. Atherosclerosis 215, 301-308.
4. Cantero, A. V., Portero-Otin, M., Ayala, V., Auge, N., Sanson, M., Elbaz, M-, Thiers, J.-C., Pamplona, R., Salvayre, R., and Nègre-Salvayre, A. (2007) Methylglyoxal induces advanced glycation end product (AGEs) formation and dysfunction of PDGF receptor-beta: implications for diabetic atherosclerosis. FASEB J. 21, 3096-3106. (Pubitemid 47565530)
5. Yokoyama, A., and Omori, T. (2003) Genetic polymorphisms of alcohol and aldehyde dehydrogenases and risk for esophageal and head and neck cancers. Jpn. J. Clin. Oncol. 33, 111-121. (Pubitemid 43102865)
6. Tinahones, F. J., Murri-Pierri, M., Garrido-Sánchez, L., García-Almeida, J. M., García-Serrano, S., García- Arnés, J., and García-Fuentes, E. (2008) Oxidative stress in severely obese persons is greater in those with insulin resistance. Obesity 17, 240-246.
7. Papazafiropouloua, A., Sklirosb, E., Ioannidisa, A., Apostoloua, O., Stamatakia, P., and Sotiropoulos, A. (2011) Serum c, zinc and selenium levels in subjects with and withou metabolic syndrome. J. Endocrinol. Metab. 1, 92-93.
8. Sultana, R., and Butterfield, D. A. (2009) Proteomics identification of carbonylated and HNE-bound brain proteins in Alzheimer's disease. Methods Mol. Biol. 566, 123-35.
9. Reed, T. T., Pierce, W. M., Markesbery, W. R., and Butterfield, D. A. (2009) Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD. Brain Res. 1274, 66-76.
10. Singh, M, Nam, D. T., Arseneault, M, and Ramassamy, C. (2010) Role of by-products of lipid oxidation in Alzheimer's disease brain: a focus on acrolein. J. Alzheimers Dis. 21, 741-56.
11. Nam, D. T., Arseneault, M., Murthy, V., and Ramassamy, C. (2010) Potential role of acrolein in neurodegeneration and in Alzheimer's disease. Curr. Mol. Pharmacol. 3, 66-78.
12. Burke, W. J. (2003) 3,4-Dihydroxyphenylacetaldehyde: a potential target for neuroprotective therapy in Parkinson's disease. Curr. Drug. Targets CNS Neurol. Disord. 2, 143-148.
13. Burke, W. J., Li, S. W., Williams, E. A., Nonneman, R., and Zahm, D. S. (2003) 3,4-Dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: implications for Parkinson's disease pathogenesis. Brain Res. 989, 205-213. (Pubitemid 37211424)
14. Koch, M., Mostert, J., Arutjunyan, A. V., Stepanov, M., Teelken, A., Heersema, D., and De Keyser, J. (2007) Plasma lipid peroxidation and progression of disability in multiple sclerosis. Eur. J. Neurol. 14, 529-33. (Pubitemid 46587841)
15. Marquez-Quiñones, A., Cipak, A., Zarkovic, K., Fattel-Fazenda, S., Villa-Treviño, S., Waeg, G., Zarkovic, N., and Guéraud, F. (2010) HNE-protein adducts formation in different pre-carcinogenic stages of hepatitis in LEC rats. Free Radical Res. 44, 119-27.
16. Cai, J., Bhatnagar, A., and Pierce, M. P. Jr (2009) Protein modification by acrolein: formation and stability of cysteine adducts. Chem. Res. Toxicol. 22, 708-716.
17. Falletti, O., and Douki, T. (2008) Low glutathione level favors formation of DNA adducts to 4-hydroxy-2(E)-nonenal, a major lipid peroxidation product. Chem. Res. Toxicol. 21, 2097-2105.
18. Wang, H.-T., Zhang, S., Hu, Y., and Tang, M.-S. (2009) Mutagenicity and sequence specificity of acrolein-DNA adducts. Chem. Res. Toxicol. 22, 511-517.
19. Liu, X. Y., Zhu, M. X., and Xie, J. P. (2010) Mutagenicity of acrolein and acrolein-induced DNA adducts. Toxicol. Mech. Methods 20, 36-44.
20. Feng, Z., Hu, W., Hu, Y., and Tang, M. S. (2006) Acrolein is a major cigarette-related lung cancer agent: Preferential binding at p53 mutational hotspots and inhibition of DNA repair. Proc. Natl. Acad. Sci. U.S.A. 103, 15404-15409. (Pubitemid 44625604)
21. Chung, F. L., Pan, J., Choudhury, S., Roy, R., Hu, W., and Tang, M. S. (2003) Formation of trans-4-hydroxy-2-nonenal- and other enal-derived cyclic DNA adducts from omega-3 and omega-6 polyunsaturated fatty acids and their roles in DNA repair and human p53 gene mutation. Mutat. Res. 531, 25-36. (Pubitemid 37456722)
22. Yoshida, A., Rzhetsky, A., Hsu, L. C., and Chang, C. (1998) Human aldehyde dehydrogenase gene family. Eur. J. Biochem. 251, 5492557.
23. Niederreither, K., Fraulob, V., Garnier, J.-M., Chambon, P., and Dollé, P. (2002) Differential expression of retinoic acid-synthesizing (RALDH) enzymes during fetal development and organ differentiation in the mouse. Mech. Dev. 110, 165-171. (Pubitemid 34020635)
24. King, G., and Holmes, R. (1998) Human ocular aldehyde dehydrogenase isozymes: distribution and properties as major soluble proteins in cornea and lens. J. Exp. Zool. 282, 12-17. (Pubitemid 28395502)
25. Harada S., Agarwal, D. P.; H. W. Goedde: Isozyme variations in acetaldehyde dehydrogenase (e.c.1.2.1.3) in human tissues. Hum. Genet. 44, 181-185.
26. Stewart, M. J., Malek, K., and Crabb, D. W. (1996) Distribution of messenger RNAs for aldehyde dehydrogenase 1, aldehyde dehydrogenase 2, and aldehyde dehydrogenase 5 in human tissues. J. Invest. Med. 44, 42-46. (Pubitemid 126820662)
27. Boesch, J. S., Lee, C., and Lindahl, R. G. (1996) Constitutive expression of class 3 aldehyde dehydrogenase in cultured rat corneal epithelium. J. Biol. Chem. 271, 5150-5157. (Pubitemid 26075011)
28. Picklo, M. J., Olson, S. J., Markesbery, W. R., and Montine, T. J. (2001) Expression and activities of aldo-Keto oxidoreductases in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60, 686-695. (Pubitemid 32619791)
29. Chen, C. H., Budas, G. R., Churchill, E. N., Disatnik, M. H., Hurley, T. D., and Mochly-Rosen, D. (2008) Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science 321, 1493-5.
30. Wang, J., Wang, H., Hao, P., Xue, L., Wei, S., Zhang, Y., and Chen, Y. (2011) Inhibition of aldehyde dehydrogenase 2 by oxidative stress is associated with cardiac dysfunction in diabetic rats. Mol. Med. 17, 172-9.
31. Chen, H. H., Sun, L., and Mochly-Rosen, D. (2010) Mitochondrial aldehyde dehydrogenase and cardiac diseases. Cardiovasc. Res. 88, 51-57.
32. Grant, R., Budas, G. R., Disatnik, M. H., Chen, C. H., and Mochly-Rosen, D. (2010) Activation of aldehyde dehydrogenase 2 (ALDH2) confers cardioprotection in protein kinase C epsilon (PKCvarepsilon) knockout mice. J. Mol. Cell. Cardiol. 48, 757-764.
33. Ma, H., Guo, R., Yu, L., Zhang, Y., and Ren, J. (2011) Aldehyde dehydrogenase 2 (ALDH2) rescues myocardial ischaemia/reperfusion injury: role of autophagy paradox and toxic aldehyde. Eur. Heart J. 32, 1025-1038.
34. Choudhary, S., Xiao, T., Vergara, L. A., Srivastava, S., Nees, D., Piatigorsky, J., and Ansari, N. H. (2005) Role of aldehyde dehydrogenase lsozymes in the defense of rat lens and human lens epithelial cells against oxidative stress. Invest. Ophthalmol. Vis. Sci. 46, 259-267. (Pubitemid 40044842)
35. Xiao, T., Shoeb, M., Siddiqui, M. S., Zhang, M., Ramana, K. V., Srivastava, S. K., Vasiliou, V., and Ansari, N. H. (2009) Molecular cloning and oxidative modification of human lens ALDH1A1: Implication in impaired detoxification of lipid aldehydes. J. Toxicol. Environ. Health, Part A 72, 577-584.
36. Lassen, N., Bateman, J. B., Estey, T., Kuszak, J. R., Nees, D. W., Piatigorsky, J., Duester, G., Day, B. J., Huang, J., Hines, L. M., and Vasiliou, V. (2009) Multiple and additive functions of ALDH3A1 and ALDH1A1: cataract phenotype and ocular oxidative damage in Aldh3a1(-/-)/Aldh1a1(-/-) knock-out mice. J. Biol. Chem. 282, 25668-25676. (Pubitemid 47372828)
37. Estey, T., Piatigorsky, J., Lassen, N., and Vasiliou, V. (2007) ALDH3A1: a corneal Crystallin with diverse functions. Exp. Eye Res. 84, 3-12. (Pubitemid 44792047)
38. Estey, T., Cantore, M., Weston, P. A., Carpenter, J. F., Petrash, J. M., and Vasiliou, V. (2007) Mechanisms involved in the protection of UV-induced protein inactivation by the corneal Crystallin ALDH3A1. J. Biol. Chem. 282, 4382-4392. (Pubitemid 47100940)
39. Murphy, T. C., Amarnath, V., Gibson, K. M., and Picklo, M. J. (2003) Oxidation of 4-hydroxy-2-nonenal by succinic semialdehyde dehydrogenase (ALDH5A). J. Neurochem. 86, 298-305. (Pubitemid 36849602)
40. Cadenas, E., Boveris, A., Ragan, C. I., and Stoppani, A. O. M. (1977) Production of superoxide radicals and hydrogen peroxide by NADH-ubiquinone reductase and ubiquinol-cytochrome c reductase from beef-heart mitochondria. Arch. Biochem. Biophys. 180, 248-257. (Pubitemid 8115490)
41. Han, D., Williams, E., and Cadenas, E. (2001) Mitochondrial respiratory chain-dependent generation of superoxide anion and its release into the intermembrane space. Biochem. J. 353, 411-416. (Pubitemid 32096952)
42. St-Pierre, J., Buckingham, J. A., Roebuck, S. J., and Brand, M. D. (2002) Topology of superoxide production from different sites in the mitochondrial electron transport chain. J. Biol. Chem. 277, 44784-44790. (Pubitemid 36159072)
43. Muller, F. L., Liu, Y., and Van Remmen, H. (2004) Complex III releases superoxide to both sides of the inner mitochondrial membrane. J. Biol. Chem. 279, 49064-49073. (Pubitemid 39625788)
44. Rodríguez-Zavala, J. S., and Weiner, H. (2002) Structural aspects of aldehyde dehydrogenase that Influence dimer-tetramer formation. Biochemistry 41, 8229-8237. (Pubitemid 34705476)
45. Rodríguez-Zavala, J. S. (2008) Enhancement of coenzyme binding by a single point mutation at the coenzyme binding domain of E. coli lactaldehyde dehydrogenase. Protein Sci. 17, 563-570.
46. Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
47. +-dependent reactions catalysed by betaine aldehyde dehydrogenase from Pseudomonas aeruginosa. Biochem. J. 352, 675-683.
48. Lakowicz, J. R. (1983) Principles of Fluorescence Spectroscopy, p 44, Plenum Press, New York.
49. Santisteban, I., Povey, S., West, L. F., Parrington, J. M., and Hopkinson, D. A. (1985) Chromosome assignment, biochemical and immunological studies on a human aldehyde dehydrogenase, ALDH3. Ann. Hum. Genet. 49, 87-100. (Pubitemid 15094862)
50. Doorn, J. A., Hurley, T. D., and Petersen, D. R. (2006) Inhibition of human mitochondrial aldehyde dehydrogenase by 4-hydroxynon-2-enal and 4-oxonon-2-enal. Chem. Res. Toxicol. 19, 102-110. (Pubitemid 43185467)
51. Nguyen, E., and Picklo, M.J.Sr. (2003) Inhibition of succinic semialdehyde dehydrogenase activity by alkenal products of lipid peroxidation. Biochim. Biophys. Acta 1637, 107-112.
52. Doorn, J. A., and Petersen, D. R. (2002) Covalent modification of amino acid nucleophiles by the lipid peroxidation products 4-hydroxy-2-nonenal and 4-oxo-2-nonenal. Chem. Res. Toxicol. 15, 1445-50. (Pubitemid 35364906)
53. Takahashi, K., and Weiner, H. (1980) Magnesium stimulation of catalytic activity of horse liver aldehyde dehydrogenase. Changes in molecular weight and catalytic sites. J. Biol. Chem. 255, 8206-8209.
54. Zhou, J., and Weiner, H. (2000) Basis for half-of-the-site reactivity and the dominance of the K487 oriental subunit over the E487 Subunit in heterotetrameric human liver mitochondrial aldehyde dehydrogenase. Biochemistry 39, 12019-12024.
55. Steinmetz, C. G., Xie, P., Weiner, H., and Hurley, T. D. (1997) Structure of mitochondrial aldehyde dehydrogenase: the genetic component of ethanol aversion. Structure 5, 701-11. (Pubitemid 27236268)